Assessment of Response to Clopidogrel by Point-of-Care Assay and its relation to Peri-procedural Myonecrosis in Patients Undergoing Coronary Stenting for Chronic Stable Angina
Mohamed Ahmed Fouad Abdalla;
Abstract
Clopidogrel is an oral, second generation thienopyridine class antiplatelet agent used to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease. It’s a prodrug that works by irreversibly inhibiting a rece
Other data
| Title | Assessment of Response to Clopidogrel by Point-of-Care Assay and its relation to Peri-procedural Myonecrosis in Patients Undergoing Coronary Stenting for Chronic Stable Angina | Other Titles | تقييم الأستجابة لعقار كلوبيدوجريل بإستخدام فحص نقطة الرعاية وعلاقته بحدوث النخر لعضلة القلب فى مرضى الذبحة الصدرية المستقرة أثناء تركيب الدعامات فى الشرايين التاجية | Authors | Mohamed Ahmed Fouad Abdalla | Keywords | Assessment of Response to Clopidogrel by Point-of-Care Assay and its relation to Peri-procedural Myonecrosis in Patients Undergoing Coronary Stenting for Chronic Stable Angina | Issue Date | 2014 | Description | Clopidogrel is an oral, second generation thienopyridine class antiplatelet agent used to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease. It’s a prodrug that works by irreversibly inhibiting a rece |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 122513G3015.pdf | 660.56 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.